Specific autologous anti-melanoma T cell response in vitro using monocyte-derived dendritic cells

Immunobiology

Volumn 198, Issue 5, 1998, Pages 527-538

  Soruri, Afsaneh ^a   Fayyazi, Afshin ^a   Gieseler, Robert ^a   Schlott, Thilo ^a   Rünger, Thomas M ^a   Neumann, Christine ^a   Peters, J Hinrich ^a  

^a Department of Immunology ^*

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MELANOMA; METASTASIS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031937835     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80076-4     Document Type: Article

References (24)

1. COOK, M. G. 1992. The significance of inflammation and regression in melanoma. Virchows Arch. A Pathol. Anat. 420: 113-115.
2. MAURER, S., and K. KOLMEL. 1997. Spontaneous regression of malignant melanoma. Cancer Res Inst, Monograph # 19.
3. ITOH, K., A. N. HOUGHTON, and C. M. BALCH. 1992. Immune responses to melanoma. In: Cutaneous Melanoma, 2nd Edition, Ed. BALCH, C. M., and A. N. HOUGHTON. J. B. Lippinscott, Philadelphia, pp. 144-164.
4. NAUTS, H. C. 1985. Bibliography of reports concerning the clinical or experimental use of Coley toxins (streptococcus pyogenes and serratia marcescens) 1893-1985. Cancer Res. Inst., New York.
5. KNUTH, A., T. WÖLFEL, and K. H. MEYER ZUM BÜSCHENFELDE. 1992. T cell responses to human malignant tumors. Cancer Surveys 13: 39-52.
6. FIDLER, I. J. 1992. The biology of melanoma metastasis. In: Cutaneous Melanoma, 2nd Edition, Ed. BALCH, C. M., and A. N. HOUGHTON. J. B. Lippinscott, Philadelphia, pp.112-129.
7. FLAMAND, V., T. SORNASSE, K. THIELEMANS, C. DEMANET, M. BAKKUS, H. BAZIN, F. TIELEMANS, O. LEO, J. URBAIN, and M. MOSER. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24: 605-610.
8. XU, H., M. KRÄMER, H. P. SPENGLER, and J. H. PETERS. 1995. Dendritic cells differentiated from human monocytes through a combination of IL-4, GM-CSF and IFN-γ exhibit phenotype and function of blood dendritic cells. 1995. Adv. Exp. Med. Biol. 378: 75-78.
9. OCKLIND, G., D. FRIEDRICHS, and J. H. PETERS. 1992. Expression of CD54, CD58, CD14, and HLA-DR on macrophages and macrophage-derived accessory cells and their accessory capacity. Immunol. Lett. 31: 253-258.
10. GIESELER, R. K. H., R.-A. RÖBER, R. KUHN, K. WEBER, M. OSBORN, and J. H. PETERS. 1991. Dendritic accessory cells derived from rat bone marrow precursors under chemically defined conditions in vitro belong to the myeloid lineage. Eur. J. Cell. Biol. 54: 171-181.
11. WERFEL, T., G. SONNTAG, M. H. WEBER, and O. GÖTZE. 1991. Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fcγ-RIII (CD16) upon stimulation of human peripheral leucocytes with human C5a. J. Immunol. 47: 3909-3914.
12. GIESELER, R., D. HEISE, A. SORURI, P. SCHWARZ, and J. H. PETERS. 1997. In-vitro differentiation of mature-type dendritic cells from human blood monocytes. Develop Immunol, in press.
13. INABA, K., M. INABA, M. DEGUCHI, R. YASUMIZU, S. IKEHARA, S. MURAMATSU, and R. M. STEINMAN. 1993. Granulocytes, macrophages, and dendritic cells arise from a common bone marrow precursor. Proc. Natl. Acad. Sci. USA 90: 3038-3042.
14. GRABBE, S., S. BEISSERT, T. SCHWARZ, and R. D. GRANSTEIN. 1995. Dendritic cells as initiators of tumor immune responses: A possible strategy for tumor immunotherapy? Immunol. Today 16:117-121.
15. CHEN, Q. V. DANIEL, D. W. MAHER, and P. HERSEY. 1994. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer 56: 755-760.
16. DUMMER, W., B. C. BASTIAN, N. ERNST, C. SCHANZLE, A. SCHWAAF, and E. B. BROCKER. 1996. Interleukin-10 production in malignant melanoma: preferential detection of IL-10 secreting tumor cells in metastatic lesions. Int. J. Cancer 66: 607-610
17. CELLUZZI, C. M., and L. D. FALO Jr 1997. Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity. J. Invest. Dermatol. 108: 716-720.
18. SEARLE, J., J. F. KERR, and C. J. BISHOP. 1982. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol. Annu. 17: 229-259.
19. STELLER, H. 1995. Mechanisms and genes of cellular suicide. Science 267: 1445-1449.
20. FAYYAZI, A., R. SCHLEMMINGER, R. GIESELER, J. H. PETERS, and H.-J. RADZUN. 1997. Apoptosis in the small intestinal allograft of the rat. Transplantation 63: 947-951.
21. SHIVER, J. W., L. Su, and P. A. HENKART. 1992. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 71: 315-322.
22. PODACK, E. R., H. HENGARTNER, and M. G. LICHTENHELD. 1992. A central role of perform in cytolysis? Annu. Rev. Immunol. 9: 129-157.
23. WATANABE FUKUNAGA, R., C. I. BRANNAN, N. G. COPELAND, N. A. JENKINS, and S. NAGATA. 1992. Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis. Nature 356: 314-317.
24. SUDA, T., T. TAKAHASHI, P. GOLDSTEIN, and S. NAGATA. 1993. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178.